0001237899-13-000032.txt : 20130509 0001237899-13-000032.hdr.sgml : 20130509 20130509165935 ACCESSION NUMBER: 0001237899-13-000032 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130507 FILED AS OF DATE: 20130509 DATE AS OF CHANGE: 20130509 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER RD CITY: TARRYTOWN STATE: NY ZIP: 10591-6707 BUSINESS PHONE: 9143477000 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Terifay Robert J CENTRAL INDEX KEY: 0001391382 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 13829724 MAIL ADDRESS: STREET 1: REGENERON PHARMACEUTICALS, INC. STREET 2: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2013-05-07 0 0000872589 REGENERON PHARMACEUTICALS INC REGN 0001391382 Terifay Robert J 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 0 1 0 0 SVP Commercial Common Stock 2013-05-07 4 M 0 14750.0 16.8 A 30074 D Common Stock 2013-05-07 4 F 0 946.0 261.67 D 29128 D Common Stock 2013-05-07 4 F 0 6857.0 261.67 D 22271 D Common Stock 2013-05-07 4 M 0 2173.0 16.8 A 24444 D Common Stock 2013-05-07 4 F 0 139.0 261.67 D 24305 D Common Stock 2013-05-07 4 F 0 750.0 261.67 D 23555 D Common Stock 2013-05-08 4 S 0 3394.0 260.86 D 20161 D Common Stock 2013-05-08 4 S 0 4437.0 261.44 D 15724 D Common Stock 2013-05-08 4 S 0 400.0 262.06 D 15324 D Common Stock 1588 I By 401(k) Plan Non-Qualified Stock Option (right to buy) 16.8 2013-05-07 4 M 0 14750.0 D 2011-12-31 2018-12-17 Common Stock 14750 2173 D Non-Qualified Stock Option (right to buy) 16.8 2013-05-07 4 M 0 2173.0 D 2018-12-17 Common Stock 2173 0 D Represents volume-weighted average price of sales of 3,394 shares of Company stock on May 8, 2013 at prices ranging from $260.58 to $260.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 8, 2013 at each separate price. Represents volume-weighted average price of sales of 4,437 shares of Company stock on May 8, 2013 at prices ranging from $261.01 to $261.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 8, 2013 at each separate price. Represents volume-weighted average price of sales of 400 shares of Company stock on May 8, 2013 at prices ranging from $262.03 to $262.13. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 8, 2013 at each separate price. On December 17, 2008, the reporting person was granted an option to purchase 48,750 shares of Common Stock. The option was eligible to vest, partially or in full, on December 31, 2011, based on the extent to which the company satisfied certain performance criteria. The performance criteria were met and the option vested as to all shares. Exercisable date, exercise date, exercise price, purchase price, sales price, and/or expiration date is/are not applicable in this case. The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant. /s/**Robert J. Terifay 2013-05-09